Genome-resolved metagenomics reveals population-dependent gut microbiome responses to albendazole-ivermectin treatment
Year: 2026
Type: preprint
Abstract: Soil-transmitted helminth control relies on mass anthelmintic treatment, yet helminth-anthelmintic-microbiome interactions and their role on treatment response remain poorly understood. We characterised the microbiome, resistome, and functional profiles of 858 paired stool metagenomes from 429 children treated with albendazole or a fixed-dose albendazole-ivermectin co-formulation in the ALIVE clinical trial in Ethiopia and Mozambique. Baseline microbiome composition differed more by country than infection status and was not associated with albendazole efficacy or adverse events. Co-formulation treatment, particularly three consecutive daily doses, was associated with depletion of Enterobacteriaceae, predominantly Escherichia coli, in Ethiopia, with reductions in E. coli-associated resistance genes and metabolic pathways. Genome-resolved analyses of over 22,000 high-quality metagenome-assembled genomes confirmed this depletion across multiple E. coli strain-level populations, linking taxonomic, resistome, and functional signals to one ecological event. These findings reveal an off-target effect of combination anthelmintic treatment relevant to large-scale deworming programmes and expand genomic resources for African gut microbiota.
Source: medRxiv
Authors: Javier Gandasegui, Pedro Fleitas, Augusto Messa, Woyneshet Gelaye, Yan Shao, Dawit Degarege, Dereje Bedane, Valdemiro Novela, Auria de Jesus, Joana Dias, Kirsty Ambridge, Nicole Sevilleno, Anna Bewsher, Terry K. Judah, Inacio Mandomando, Wendemagegn Enbiale, Trevor Lawley, Alejandro Krolewiecki, Jose Munoz, Stephen R. Doyle
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Funders: Wellcome Trust, UK Research and Innovation, European Commission, Consejo Nacional de Investigaciones Científicas y Técnicas, Universidade Nova de Lisboa, Universidad Nacional de Salta, Fundación Mundo Sano, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, European and Developing Countries Clinical Trials Partnership
Awards: G1148816448, Structural and biophysical mechanism of microRNA nuclear export, Wellcome Sanger Institute Quinquennial Review 2021-2026, STOP 2030: TOWARDS THE INTERRUPTION OF TRANSMISSION OF SOIL-TRANSMITTED HELMINTHS: PROMOTING IMPLEMENTATION OF RESEARCH RESULTS OF A FIXED-DOSE COMBINATION OF CO-FORMULATED IVERMECTIN AND ALBENDAZOLE, Wellcome Sanger Institute Quinquennial Review 2021-2026, Towards the interruption of transmission of soil-transmitted helminths: Clinical research development of a fixed-dose co-formulation of ivermectin and albendazole, G5645273643, G9000285489, G95435288
OpenAlex ID: W7236278949
